SLGL Stock Analysis: Buy, Sell, or Hold?
SLGL - Sol-Gel Technologies Ltd. Ordinary Shares
$72.00
-1.00 (-1.37%)
âŧ
5d:
+7.7%
30d:
+2.23%
90d:
-2.86%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 19, 2026
Get Alerted When SLGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SLGL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SLGL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SLGL is currently trading at $72.00, which is considered slightly high relative to its 30-day fair value range of $62.79 to $72.53.
Technical Outlook: Technically, SLGL is showing sideways momentum. Immediate support is located at $58.30, while resistance sits at $77.67.
Market Sentiment: SLGL scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $152.50 (+111.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLGL is showing sideways momentum. Immediate support is located at $58.30, while resistance sits at $77.67.
Market Sentiment: SLGL scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $152.50 (+111.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$62.79 -
$72.53
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 111.8% below Wall St target ($152.50)
- WARNING: Composite score 28/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$62.79 -
$72.53
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$58.30
Resistance Level
$77.67
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.60
Wall Street Target
$152.50
(+111.8%)
Revenue Growth (YoY)
-96.6%
Earnings Growth (YoY)
487.6%
Share & Embed Analysis
Last updated: October 04, 2026 1:59 AM ET
Data refreshes hourly during market hours. Next update: 2:59 AM
Data refreshes hourly during market hours. Next update: 2:59 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
RNA
Atrium Therapeutics, IncâĻ |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 51 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
13 analysts |
$107 | 67 BUY |
